← Leaderboards
Denis Evseenko
University Of Southern California
$6,343,002
Attributed
$8,412,291
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,412,291 · 7
By mechanism
R01$5,305,752 · 3
R61$1,348,453 · 1
UG3$943,301 · 1
K01$581,085 · 1
R43$233,700 · 1
Top collaborators
- Karen M. Lyons8 shared
- Toby Michael Maher1 shared
- Ben Van Handel1 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Joseph Leo Wiemels$16,840,536
- Darian Gamble$91,712
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectJointsIn VivoMorbidity - Disease RateCellsProgenitorAdultArticular CartilageCartilageSurfaceDegenerative PolyarthritisCartilage InjuryChondrocytesChondrogenesisCartilage RepairBaseRestorationCytokineSmall MoleculeReceptorPathogenesisIl6st GeneInterleukin-6Signal Transduction
Grant awards (23)
Pre-clinical development of a small molecule therapeutic for the systemic treatment of idiopathic pulmonary fibrosis$943,301
UG3 · FY2025 · AG · contact PI
Cellular origins and molecular mechanisms of arthrofibrosis$628,174
R01 · FY2025 · AR · contact PI
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain$1,348,453
R61 · FY2023 · NS · contact PI
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage$338,250
R01 · FY2023 · AG · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$513,114
R01 · FY2022 · AR · contact PI
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage$338,250
R01 · FY2022 · AG · contact PI
Advancement of a lead small molecule gp130 modulator for improving outcomes in joint fibrosis$233,700
R43 · FY2022 · AR
GP130/STAT3 signalling in articular cartilage development and regeneration$70,985
R01 · FY2022 · AR · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$553,025
R01 · FY2021 · AR · contact PI
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage$338,250
R01 · FY2021 · AG · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$70,985
R01 · FY2021 · AR · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$570,129
R01 · FY2020 · AR · contact PI
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage$338,250
R01 · FY2020 · AG · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$54,889
R01 · FY2020 · AR · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$570,129
R01 · FY2019 · AR · contact PI
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage$363,000
R01 · FY2019 · AG · contact PI
GP130/STAT3 signalling in articular cartilage development and regeneration$558,322
R01 · FY2018 · AR · contact PI
Generation of human chondroprogenitor cells for cartilage restoration$101,235
K01 · FY2015 · AR · contact PI
Generation of human chondroprogenitor cells for cartilage restoration$14,854
K01 · FY2015 · AR · contact PI
Generation of human chondroprogenitor cells for cartilage restoration$116,249
K01 · FY2014 · AR · contact PI
Generation of human chondroprogenitor cells for cartilage restoration$116,249
K01 · FY2013 · AR · contact PI
Generation of human chondroprogenitor cells for cartilage restoration$116,249
K01 · FY2012 · AR · contact PI
Generation of human chondroprogenitor cells for cartilage restoration$116,249
K01 · FY2011 · AR · contact PI